office of news communications
Awards, News Briefs and Announcements
Image from Temple Department of Mechanical Engineering Chair Mohammad Kiani, PhD, FAHA.
December 4, 2013. Funded by a three-year, $600,000 grant from Shriners Hospitals for Children, Barbara Krynska, MS, PhD, Assistant Professor of Neurology at the Shriners Hospitals Pediatric Research Center at Temple University School of Medicine, and Mohammad Kiani, PhD, FAHA, Chair of Mechanical Engineering at Temple University, are leading the development of a pediatric blood-brain barrier system on a chip. This initiative will offer great potential for studying the role of the blood-brain barrier in pediatric neurological diseases and testing the blood-brain-barrier permeability of various therapeutic drugs.
Image: At the APSA conference (L-R): Isha Srivastava, event co-chair and MD-PhD candidate; Lindsey Gerngross, MD-PhD candidate and poster competition winner; Evan Noch, MD-PhD ’12, APSA President and Temple alumnus; and Kaitlin Collura, MD-PhD candidate and event co-chair.
November 7, 2013. On November 2, Temple University School of Medicine hosted the 7th annual northeast regional meeting of the American Physician Scientists Association (APSA), a national organization devoted to meeting the career-development needs of future physician-scientists.
The day-long event, which drew more than 160 attendees from seven states, featured four keynote addresses, a poster session and competition showcasing more than 30 student research projects, and small- group discussion sessions devoted to 11 different topics.
In his keynote address, which launched the conference, Arthur M. Feldman, MD, PhD, Executive Dean of Temple University School of Medicine and Chief Academic Officer of Temple University Health System, gave the future physician-scientists six essential tips for constructing a supportive framework for their lives and careers. Three additional talks, interspersed throughout the day, were made by Susan Morgello, MD, of Mount Sinai Medical Center (NY), and Stephen Ostroff, MD, and Carol Weiss, MD-PhD, both of the U.S. Food and Drug Administration.
Lindsey Gerngross, an MD-PhD candidate at Temple, won a prize in the poster competition for her presentation of research targeting a specific monocyte subset for the prevention and treatment of HIV-associated neurocognitive disorders. Two students from Thomas Jefferson University and Drexel University College of Medicine won prizes as well.
Eight Temple faculty members led group discussion sessions and/or judged the poster session: Philip Cohen, MD (Rheumatology); James Heckman, PhD (Physiology); John Krouse, MD (Otolaryngology); Curtis Miyamoto, MD (Radiation Oncology); Darilyn Moyer, MD (Internal Medicine); Stephen Permut, MD, JD, (Family and Community Medicine) Scott Shore, PhD (Biochemistry); and Dianne Soprano, PhD (Biochemistry).
“This was the perfect meeting for MD/PhD students, medical students interested in research/academic pathways, PhD students interested in medical school–even undergraduate students interested in physician-scientist degree programs,” said Temple alumnus Evan Noch, MD, PhD, the President of APSA and a first-year neurology resident at Weill-Cornell Medical Center-New York Presbyterian Hospital in New York. “I was proud to see my alma mater host the event and do such a great job.”
Isha Srivastava and Kaitlyn Collura, MD-PhD candidates at Temple, co-chaired the organizing committee for the event, which was sponsored by APSA, Temple, Drexel University School of Medicine, and Thomas Jefferson University, with additional support from the University of Pennsylvania.
Image: Oneida A. Arosarena, MD, FACS (standing) with Senior Lab Super visor Roshanak Razmpour
October 30, 2013. The spread of oral cancer into bone tissue can be extremely painful and distressing for patients, since it is a sign of advanced disease. The condition affects about 10 to 30 percent of oral cancer patients; but in minority populations, where access to health care may be lacking, the incidence can be much higher. To add to doctors’ concerns, there are few drugs capable of treating oral bone invasion, a situation that has inspired a hunt for biological molecules linked to the disease that could serve as targets for new therapeutic agents.
One of the leaders in that effort is Oneida A. Arosarena, MD, FACS, Associate Professor in the Department of Otolaryngology, Head and Neck Surgery at the Temple University School of Medicine (TUSM). Dr. Arosarena recently was awarded a grant from the National Institutes of Health (NIH) to spearhead a preliminary investigation into osteoactivin, a potential drug target for bone invasion in oral cancer.
In previous work, Dr. Arosarena determined that osteoactivin is active in oral cancer and found that it is expressed to varying degrees in different types of oral cancer cells. Cells that had significantly elevated osteoactivin levels came from highly aggressive oral tumors, the ones most likely to undergo bone invasion.
The finding suggested that osteoactivin could be more than a drug target – and that it could serve as an indicator, or marker, of aggressive forms of oral cancer. In theory, then, the assessment of osteoactivin levels could help identify patients with high osteoactivinexpressing tumors and thereby allow for earlier treatment. Oral cancer in its earliest stages is a curable disease.
Image: Members of Temple's Radiation Oncology Department who presented at the Science Council session, (left to right): Vladimir Valakh, MD; Pierre Charpentier, MS; Shidong Li, PhD; Philip Chan, MS; and Curtis Miyamoto, MD. Not pictured: Toni Neicu, PhD, and Bizhan Micaily, MD.
October 21, 2013.Under the direction of Shidong Li, PhD, Temple University Hospital (TUH) Medical Physicists presented their latest research findings during the 2013 Science Council Session at the American Association of Physicists in Medicine's annual meeting in Indianapolis, Indiana. Temple's presenters hosted a two-hour seminar entitled, Multi-Modality Imaging in Radiation Oncology: Planning, Guidance, and Assessment of Treatment Response.
"We were truly honored to have the opportunity to present our findings to a group of the best physicists and physicians in the world," said Dr. Li, Temple University Hospital's Chief Medical Physicist.
"Our presentation described a new approach in Cone-beam-CT guidance to measure and track early-stage lung cancer nodules with great accuracy during radiation therapy. A patient's body and its internal organs are constantly shifting during therapy due to breathing, and our approach combined with a 4D optical monitoring system, currently under clinical testing, is able to monitor the patient's position in real-time – allowing us to position the radiation beam so that it remains precisely focused on the tumor, avoiding healthy tissue. In the coming months, we are looking to publish a paper to describe our findings in greater detail," Dr. Li added
October 15, 2013. Two years ago, when Temple researcher Domenico Praticò, MD, shared some of his earlier findings and ongoing hypotheses about the causes of Alzheimer's Disease at a community meeting sponsored by the Alzheimer's Association, he had no idea that his unflagging passion for finding a cure for the disease would inspire one member of that audience to ultimately bequeath $350,000 to fund his future investigations.
"At the time, I didn't realize that my talk about our research would result in this generous gift," said Dr. Praticò, Professor of Pharmacology and Microbiology and Immunology at Temple University School of Medicine. Dr. Praticò learned later that his anonymous benefactor had watched her father deteriorate and die from the devastating effects of Alzheimer's disease.
A review of Dr. Praticò's groundbreaking and promising work helps explain why his benefactor chose to support his research. In a prior study funded by the National Institutes of Health, Dr. Praticò and his team were the first in the world to identify a protein in the brain (12/15-Lipoxygenase) that, when produced excessively, leads to the development of plaques characteristic of Alzheimer's disease. Their significant work, which documented the biochemical chain-reaction set-off by the protein, was published in the Annals of Neurology in 2012.
The researchers' dual discoveries also set the stage for the next phase of their work – which would focus on blocking the excessive production of the protein, thereby preventing the creation of Alzheimer's–related plaques.
"If excessive 12/15-Lipoxygenase can be blocked, perhaps Alzheimer's can be thwarted," suggests Dr. Praticò. Most recently, the scientists have identified two compounds that appear to be most promising in blocking or modulating the expression of 12/15-Lipoxygenase.
Using animal models, Dr. Praticò's lab is currently testing the ability of the compounds to both inhibit the development of the disease and inhibit its growth once the tell-tale signs of Alzheimer's have been detected.
"Alzheimer's is a disease that steals from us what makes us human – our memories, our cognitive abilities," Dr. Praticò says softly. "We have learned a tremendous amount about it in the last decade or so, but we still have a long way to go … and research is the way we forge ahead."
Not only will the $350,000 unrestricted gift help fund Dr. Praticò's current investigations, but, due to a dollar-for-dollar "matching" stipulation in his benefactor's will, it has the potential to double the funds available to support his work.
"I am extremely grateful for the wonderful gift we have received – which gives us the freedom to explore new avenues of research that, if successful, will be highly rewarding," adds Dr. Praticò.
Make a donation to Temple's Alzheimer's Research Fund by visiting http://giving.temple.edu/alzheimer.
October 10, 2013. John H. Krouse, MD, PhD, Professor and Chairman of Temple's Department of Otolaryngology-Head and Neck Surgery and Associate Dean of Graduate Medical Education at Temple University School of Medicine, has been named the incoming Editor-in-Chief of Otolaryngology – Head and Neck Surgery, the official, peer-reviewed journal of the American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNS). The AAO-HNS Foundation works to promote the advancement of the art, science and ethical practice of otolaryngology-head and neck surgery through education, research and lifelong learning.
Dr. Krouse will assume his new position on October 1, 2014, succeeding Richard M. Rosenfeld, MD, MPH, Professor and Chairman of Otolaryngology at SUNY Downstate Medical Center in New York. Presently, Dr. Krouse serves as an Associate Editor for the journal—a position he has held for the past seven years.
"I am the first to recognize the sizable shoes that I must fill by having the honor and privilege of succeeding Dr. Rosenfeld as editor-in-chief of Otolaryngology – Head and Neck Surgery," said Dr. Krouse. "I look forward to ensuring that Oto-HNS remains the primary source for dissemination of clinical and scientific knowledge in our broad specialty."
Dr. Krouse is board-certified in otolaryngology and specializes in rhinology and allergy. He has contributed to more than 125 articles in various publications, several book chapters and five textbooks. Additionally, he has presented numerous papers at national and international meetings.
His research interests include allergic and nonallergic rhinitis, local nasal immunity, chronic rhinosinusitis, endoscopic sinus surgery, asthma and sleep.
October 2, 2013. Gil Yosipovitch, MD, Professor and Chair of the Department of Dermatology at Temple University School of Medicine, has been named the first-ever recipient of the Dr. Jeffrey D. Bernhard
The award will be given out every two years to a recipient who demonstrates outstanding contributions to clinical research in the field of itch. The winner of the award is also asked to deliver the Bernhard Distinguished Lecture at the World Congress of Itch.
Dr. Yosipovitch is an internationally recognized leader in the clinical aspects of itch, and is a renowned clinician and investigator into the causes and treatments of complex skin diseases – including eczema, psoriasis, and diseases of other organ systems with skin manifestations.
In addition to being Professor and Chair of the Department of Dermatology at Temple University School of Medicine, Dr. Yosipovitch is also leading the dermatologic program at Fox Chase Cancer Center, and is directing the development of a dedicated Center for Itch on Temple's Health Sciences Campus.
Image: Dr. Larry Kaiser with Dr. Reddy and his portrait, painted by Joseph Routon.
October 1, 2013. On September 27, Temple University School of Medicine presented a day-long symposium to honor E. Premkumar Reddy, PhD, the internationally recognized scientist who headed The Fels Institute for Cancer Research and Molecular Biology at Temple for 18 years, from 1992 to 2010. Today Reddy serves as Director of Experimental Cancer Therapeutics at Mt. Sinai University School of Medicine in New York, and continues to have a significant voice in molecular oncology.
New biomedical sciences students – and four visiting students from Brazil – along with Dianne Soprano, PhD, Associate Dean (far left), and Scott Shore, PhD, Associate Dean (far right).
August 29, 2013. The Temple University School of Medicine (TUSM) Biomedical Sciences Graduate Program welcomes 24 new students, plus four visiting students from Brazil.
Seventeen of the degree-program students are doctoral (PhD) candidates, and seven are pursuing a Master’s degree. Temple was once again successful in attracting international students to the program (six, who hail from Chile, China, and Turkey) and four American students representing ethnicities considered underrepresented in science and medicine.
TUSM’s biomedical graduate students can choose among five different concentrations: cancer biology and genetics; infectious disease and immunity; molecular and cellular biosciences; neuroscience; and organ systems and translational medicine.
“Our students are expertly prepared for roles in academia, government, and industry,” says Dianne Soprano, PhD, Associate Dean of Graduate and MD/PhD Programs, “They receive outstanding mentoring from our faculty – all premier researchers with national and international reputations.”
The visiting students are part of the Brazil Scientific Mobility program, a Brazilian government-sponsored initiative that gives Brazilian medical and university students the opportunity to take basic science courses and gain research experience in the United States prior to completing their degrees in Brazil.
Dr. Domenico Praticò (left) and Dr. Jin Chu (right) with Mrs. Jannett Caldwell of the Alzheimer's Art Quilt Initiative.
August 26, 2013. On August 22, representatives of the Alzheimer's Art Quilt Initiative® (AAQI) visited Temple University School of Medicine for two reasons: To present a past AAQI grant recipient, Domenico Praticò, MD, Professor of Pharmacology and Microbiology and Immunology, with an award for his commitment to Alzheimer's disease research – and to present a new research grant to his colleague Jin Chu, PhD, Assistant Scientist in Dr. Praticò's laboratory.
In 2012, Dr. Praticò was awarded a $60,000 grant from the Alzheimer's Art Quilt Initiative (AAQI) to investigate the role that psychological stress plays in the development of Alzheimer's disease. He used it in combination with funding from the National Institutes of Health to examine how increased stress hormone levels accelerate the development of Alzheimer's disease. The ultimate objective of the research is to identify the mechanisms that trigger this effect so that therapeutic strategies can be developed.
"When the levels of the stress hormone corticosteroid are too high for too long, they can damage or cause the death of neuronal cells, which are very important for learning and memory," Dr. Praticò said.
In the course of the study, Dr. Praticò found that that high levels of corticosteroid activate a protein called 5-lipoxygenase that damage the synapse, resulting in memory and learning impairment, key symptoms for Alzheimer's. The research, published in the journal Aging Cell, documents what Dr. Praticò calls "evidence of the earliest type of damage that precedes memory deficit in Alzheimer's patients."
"This is strong support for the hypothesis that if you block 5-lipoxygenase, you can probably block the negative effects of corticosteroid in the brain," Dr. Praticò added.
In addition to honoring Dr. Praticò for his contributions to Alzheimer's Research, the AAQI honored Dr. Praticò for serving as a volunteer member of its Scientific Advisory Board.
The AAQI's new grant, awarded to Dr. Chu, is titled "Five Lipoxygenase and Alzheimer's Related Tau Pathology." This funding will enable her to unravel new lipid signaling pathways that control the formation and metabolism of the tau protein, whose accumulation in the brain, together with the amyloid-beta, is considered the main culprit for the development of Alzheimer's disease.
The AAQI, based in Burton, Michigan, is a national, grassroots charity that raises awareness of Alzheimer's disease and funds promising research. The AAQI auctions and sells donated quilts and sponsors a nationally touring exhibit of quilts about Alzheimer's.
August 8, 2013. Selwyn O. Rogers, Jr., MD, MPH, FACS, Surgeon-in-Chief of Temple University Health System, and Professor and Chair of the Department of Surgery at Temple University School of Medicine, has been named a "Minority Business Leader" at the 2013 Minority Business Leader Awards, sponsored by the Philadelphia Business Journal. Dr. Rogers accepted his award at a breakfast ceremony on Thursday, August 8, at the Crystal Tea Room in Philadelphia.
The Minority Business Leader Awards recognize executives with ethnic backgrounds who also play a strong leadership role outside their jobs and serve in industry associations or community organizations.
An internationally renowned academic surgeon, teacher, mentor, researcher, administrator and innovator in community service, Dr. Rogers joined Temple in July 2012 to direct the future growth of the Department of Surgery at Temple University School of Medicine. Dr. Rogers has published dozens of research articles on health care disparities and the effect of race and ethnicity on surgical outcomes.
Dr. Rogers has a deep-rooted commitment to caring for the customarily underserved and to increasing the number of minority physicians in this country, especially in the area of surgery. To that end, he regularly speaks to undergraduate students and encourages them to chase their dreams no matter how big they are. He also serves as a role model and mentor for both minority and majority students and young surgeons at Temple.
August 6, 2013. Officials of Temple University Hospital and the Temple University Hospital Auxiliary recently gathered to celebrate the completion of the Auxiliary's half million-dollar pledge to the Mary F. and John M. Daly Ambulatory Surgical center at Temple University Hospital. Theirs was the lead gift in the funding that made the facility possible.
"Each year, the Auxiliary selects a focal point for its philanthropy," said Mary McNamara, Auxiliary President. "For several reasons the surgery center was the ideal choice for 2011."
First, a new ambulatory surgery center was a capital priority for the hospital. The spacious, modern and beautifully appointed new center features four surgical suites that Temple surgeons use for cases ranging from minor surgeries to more complex laparoscopic procedures.
Further, naming the gift enabled the Auxiliary to honor two important people: Mary Daly, a beloved Auxilian who passed away in 2011, and her surviving husband, John M. Daly, MD, emeritus dean of Temple University School of Medicine – a surgeon and a graduate of Temple’s medical school.
"The Auxiliary has been a tremendous asset to Temple for nearly 60 years, and we never take for granted the important role it has played in the life of this institution," said John Kastanis, FACHE, President and CEO of Temple University Hospital. "With philanthropy and capital funding so competitive in today's economy, the Auxiliary's support is more important than ever before."
Since its founding in 1944, the Auxiliary has provided more than $5 million in support for Temple University Hospital, raising money by conducting sales, fund raisers and social gatherings throughout year. New members are welcome. For more information, contact Rita G. Brouwer-Ancher at 215-707-4898.
July 26, 2013. Temple University School of Medicine (TUSM) has launched a new Center for Metabolic Disease Research, which is committed to performing basic and clinical research identifying specific causes of metabolic diseases, and to discovering novel therapies for these diseases.
“Metabolic disease research is one of the major targeted areas for National Institutes of Health (NIH) funding, and TUSM leadership has responded to this call by designating it as one of the school’s four key research focus areas, along with cardiovascular, neuroscience, and cancer research,” said Arthur M. Feldman, MD, PhD, Executive Dean, TUSM and Chief Academic Officer, Temple University Health System. “Establishing a Center for Metabolic Disease Research is strategically important and timely because we will simultaneously carry out TUSM’s research mission, remain consistent with the NIH’s research focus, and reflect the national trend of interdisciplinary and translational health-related research,” Dr. Feldman added.
Metabolic disorders – which occur when abnormal chemical reactions disrupt the body’s ability to convert food to energy – can cause serious dysfunctions in the blood vessels, heart, liver, brain, and other organs. Metabolic dysfunctions have been recognized to be important mechanisms underlying diabetes and many other diseases, such as cardiovascular, endocrine, kidney, genetic, bone, and immune diseases.
“Temple’s Center for Metabolic Disease Research will develop interdisciplinary and translational research programs focused on metabolic diseases such as hyperlipidemia, hyperhomocysteinemia, hyperglycemia, obesity, uremia and metabolic syndrome. Our research will study the biochemical, molecular, cellular, and pathological changes that take place before the onset of these diseases and during the course of these diseases,” said TUSM Associate Dean of Research Hong Wang, MD, PhD, EMBA, who has been named the Founding Director of the new Center. Dr. Wang is also Professor in Temple University School of Medicine’s Department of Pharmacology, Independence Blue Cross Cardiovascular Research Center, and Sol Sherry Thrombosis Research Center.
As a world-renowned and nationally-recognized leader for the pioneering research in hyperhomocysteinemia (HHcy), a significant and independent risk factor for cardiovascular disease, Dr. Wang has extensive expertise and high-profile publications in the areas of cardiovascular inflammation, atherosclerosis, lipoprotein metabolism, vascular function, molecular mechanism, and signal transduction. Dr. Wang’s research focuses on identifying biochemical mechanisms of vascular disease and discovering therapeutic targets and novel therapeutic strategies. Dr. Wang is the principal investigator on several active NIH-funded Research Project Grant Program (R01) studies.
“Our Center is also employing multidisciplinary approaches for drug discovery, for example, metabolite identification (the chemical fingerprints that specific cellular metabolic processes leave behind), metabolomic screening, next-generation sequencing, proteomics, and high-throughput drug screening to discover new therapeutic targets and identify drug leads,” noted Dr. Wang.
Temple’s Center for Metabolic Disease Research has established a human tissue repository to collect plasma, blood, vessel tissue, and fat tissue samples from patients with a variety of metabolic and cardiovascular diseases, and it will also test novel therapeutics in human metabolic disease-related chronic tissue ischemia using cell and gene therapy approaches.
“We are confident that our Center will grow and become one of the top research enterprises in the field of metabolic disease research,” Dr. Wang added.
June 28, 2013. Michael W. Weaver, MD, Associate Professor of Neurosurgery at Temple University School of Medicine (TUSM), has been appointed Chair of the Department of Neurosurgery at TUSM. He has served as Interim Chair of the Department since August 2012 and was selected after a national search.
Board-certified in neurological surgery, Dr. Weaver completed his undergraduate education at Franklin and Marshall College, and earned his MD degree from Temple University School of Medicine. He remained at Temple after graduation to complete a general surgery internship and a neurosurgery residency. Dr. Weaver also completed a six-month pediatric neurosurgery residency at Children’s Memorial Hospital in Chicago, and a six-month Neurosurgical Fellowship at Boston Children’s Hospital and Brigham and Women’s Hospital before returning to Temple.
In addition to his other roles, Dr. Weaver also currently serves as Medical Director of Temple’s Neurosurgical Intensive Care Unit. His clinical interests include neuro-oncology, intracranial procedures involving skull-based surgery, and cerebrovascular surgery. Dr. Weaver is also a dedicated researcher with past and current work in the areas of neuro-oncology and cerebrovascular research. He and his colleagues are also actively involved in developing brain tumor protocols.
Dr. Weaver has been named a “Rising Star” in Philadelphia magazine’s “Top Doctors” list. He is an inductee of Temple University School of Medicine’s Epsilon Chapter of the Alpha Omega Alpha Honor Society, and is the recipient of the Medical School’s Augustine R. Peale Award and Mary Wiederman Award in Physiology. Dr. Weaver is a member of a number of professional organizations and specialty societies, including the American Medical Association, the American Association of Neurological Surgeons, the American College of Surgeons, and the Pennsylvania Medical Society. He has also made numerous original contributions to the medical literature, and been asked to make nearly two dozen lectures and presentations at international and national meetings.
June 10, 2013. Jocelyn Edathil, MD, PhD, a third-year internal medicine resident at Temple University Hospital, has earned the Vanitha Appadorai Vaidya, MD Award for Humaneness in Medicine from the Philadelphia County Medical Society. The award is presented to a resident or fellow in recognition of their skills in working with people, patients and their families, and understanding human as well as clinical needs.
Dr. Edathil has a special interest in HIV research and translational medicine. She earned her PhD in organic chemistry focusing on antiviral drug design. At the completion of her residency, Dr. Edathil plans to become a missionary and focus on global health in HIV.
She received the award during a June 8 ceremony at the Rittenhouse Hotel in Philadelphia.
June 10, 2013. Curtis Miyamoto, MD, Professor and Chair of the Department of Radiation Oncology at Temple University School of Medicine, has been installed as the 152nd President of the Philadelphia County Medical Society (PCMS). He was elected by his peers and will serve as president of PCMS for one year.
Dr. Miyamoto has been a member of PCMS and the Pennsylvania Medical Society (PAMED) since 2002. He has served on the PCMS Board of Directors as past Treasurer, past Delegate-at-Large and President-Elect. Dr. Miyamoto has also served as mentor for the PCMS Medical Student Section and is currently a Delegate to the PAMED House of Delegates.
“I am extremely honored to be the 152nd President of the Philadelphia County Medical Society,” said Dr. Miyamoto. “I look forward to leading the organization and bringing talented people together to create solutions to problems that are challenging the healthcare community at large.”
Dr. Miyamoto’s clinical and research interests include general external beam radiation; 3-D conformal radiotherapy; stereotactic radiosurgery and radiotherapy; intensity modulated radiation therapy; image-guided radiation therapy; Gamma Knife® treatments; translational research; brain tumors and disorders; and prostate, lung, breast and gastrointestinal cancers. He earned his MD from the Universidad de Navarra in Pamplona, Spain, and went on to complete a radiation oncology residency and a radiation oncology and nuclear medicine research fellowship at Hahnemann University Hospital. Dr. Miyamoto also completed a fellowship with the American Cancer Society.
Dr. Miyamoto was installed as president of PCMS during a June 8 ceremony at the Rittenhouse Hotel in Philadelphia.
May 20, 2013. Joseph Cheung, MD, PhD, Senior Associate Dean for Research and Professor of Medicine at Temple University School of Medicine, and Xiao-Feng Yang, MD, PhD, Professor of Pharmacology, Professor at the Cardiovascular Research Center and Professor at the Sol Sherry Thrombosis Research Center at Temple University School of Medicine, have been selected for prestigious posts as members of National Institutes of Health (NIH) study sections.
Members of NIH study sections are seasoned experts in their scientific disciplines, and selected on the basis of their research accomplishments, publication records and scientific honors. Study section members review grant applications submitted to the NIH from investigators all over the country, make recommendations on the applications to national advisory councils and survey the status of research in their fields.
Dr. Cheung has been selected for the NIH Electrophysiology, Signal Transduction and Arrhythmias Study Section. Dr. Yang has been selected for the Atherosclerosis and Inflammation of the Cardiovascular Systems Study Section. Their selections are effective July 1, 2013, and carry terms of five to six years.
“Membership on a study section represents a unique opportunity to contribute to the national biomedical research effort,” said Richard Nakamura, PhD, Director of the NIH Center for Scientific Review. “The functions are of great value to medical and allied research in this country.”
April 8, 2013. Darilyn V. Moyer, MD, FACP, has been named Chair-elect of the Board of Governors of the American College of Physicians (ACP), the nation’s largest medical specialty organization. Dr. Moyer’s term will begin at the conclusion of Internal Medicine 2013, ACP’s annual scientific meeting in San Francisco, CA., April 11-13.
Dr. Moyer is currently serving as Governor of ACP’s Pennsylvania Southeastern Chapter. Governors are elected by local ACP members and serve four-year terms. Working with a local council, they supervise ACP chapter activities, appoint members to local committees, and preside at regional meetings. They also represent members by serving on the ACP Board of Governors. She has been a Fellow of the ACP (FACP) since 1995. FACP is an honorary designation that recognizes ongoing individual service and contributions to the practice of medicine.
Dr. Moyer is the Vice Chair and Internal Medicine Program Director, Department of Medicine, and Assistant Dean for Graduate Medical Education, Temple University School of Medicine and Temple University Hospital. She is a Professor of Medicine and Assistant Dean for Graduate Medical Education at Temple University School of Medicine. She is board certified in Internal Medicine and has completed Maintenance of Certification in Infectious Disease.
She received her Bachelor of Arts degree in the Biological Basis of Behavior, Biology and Psychology from the University of Pennsylvania and attended medical school at Temple University School of Medicine. She completed her Internal Medicine Residency at Temple University Hospital and served as a Chief Resident/Clinical Instructor of Medicine. She went on to complete an Infectious Diseases Fellowship at Harbor-UCLA Medical Center in Torrance, CA.
Dr. Moyer is on the faculty in the Department of Medicine at Temple University School of and is an active practitioner in primary care, HIV and Infectious Diseases. She received the Temple University School of Medicine Women in Medicine Mentoring Award in 2012.
Her research and scholarly activity interests and presentations include those in the medical education, high value care, patient safety, professionalism and digital media and HIV/Infectious Diseases realm. She is the Co-Faculty Advisor for the Temple University School of Medicine Internal Medicine Interest Group and for the Temple University School of Medicine Student Educating About Healthcare Policy group.
The American College of Physicians (www.acponline.org) is the largest medical specialty organization and the second-largest physician group in the United States. ACP members include 133,000 internal medicine physicians (internists), related subspecialists, and medical students. Internal medicine physicians are specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults across the spectrum from health to complex illness. Follow ACP on Twitter (www.twitter.com/acpinternists) and Facebook (www.facebook.com/acpinternists).
Follow us on:
Assistant Vice President
Department of Communications
Temple University Health System
3509 N. Broad St., 9th Floor
Philadelphia, PA 19140